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To date, there has been only one study comparing costs of outpatient versus inpatient
TSA. This study sought to understand the differential costs, complications, and
readmission rates between TSAs performed in an outpatient versus inpatient setting in
lieu of the Affordable Care Act and ICD-10. Archival data were obtained from Medicare
5% limited data set and MarketScan® privately insured billing data from 2016 for patients
aged 55-74, propensity score matching 1:1 to ensure similar propensity for surgery in the
outpatient setting. In total, 1,578 patients underwent TSA in our dataset: 374 outpatient
and 1,204 inpatient. Following propensity score matching, 738 well-matched TSA
patients were included in this study—369 each in inpatient and outpatient. In adjusted
analysis, total costs for inpatient TSA were 87% higher than outpatient $36,033 vs.
$19,253 (p=0.0001). For overall complication rates, inpatient TSAs had an approximately
54% overall lower odds of a medical or surgical complication than those performed in an
outpatient setting (Odds ratio [OR] 0.436, 95% CI: 0.236-0.806, p=0.008). In conclusion,
our results show that outpatient TSA provides a significant cost reduction. However,
there was an increase in odds of complication, which is contrary to previous work.
Therefore, future work should focus on evaluating outpatient TSA, its value, and its
safety within ICD-10 and the ACA. Additionally, healthcare leaders should focus on
identifying and directing high-risk patients toward inpatient settings, while focusing on
value.

iii

TABLE OF CONTENTS

Acknowledgements .................................................................................................... i
Abstract...................................................................................................................... iii
List of Tables ............................................................................................................ vi
List of Figures ......................................................................................................... vii
I.

INTRODUCTION ...................................................................................................... 1

II.

REVIEW OF THE LITERATURE ............................................................................ 6
Population & Osteoarthritis .............................................................................. 6
Total Joint Arthroplasty & Volume .................................................................. 6
Total Shoulder Arthroplasty & Volume ........................................................... 7
Safety of Total Joint Arthroplasty..................................................................... 8
Total Shoulder Arthroplasty & Complication Risk Factors ............................. 9
Outpatient Total Shoulder Arthroplasty & Safety .......................................... 11
Outpatient Total Joint Arthroplasty – Protocols & Pathways ......................... 13
Total Joint Arthroplasty & Costs .................................................................... 17
Bundled Care Payment Initiative (BCPI) ....................................................... 18
Outpatient Total Shoulder Arthroplasty– Costs & Value ............................... 21
Total Shoulder Arthroplasty & Cost Savings ................................................. 22

III.

METHODOLOGY ................................................................................................... 26
Specific Aims and Hypotheses ....................................................................... 26
Study Design ................................................................................................... 27
Population and Sample ................................................................................... 28
Database .......................................................................................................... 30
Definition of Variables ................................................................................... 31
Dataset Description ......................................................................................... 36
Data Analysis .................................................................................................. 36
Limitations ...................................................................................................... 37

IV.

ARTICLE MANUSCRIPT ...................................................................................... 39
Introduction ..................................................................................................... 39
Methods........................................................................................................... 42
Data .......................................................................................................... 42
Study & Control Cohorts ......................................................................... 43
Propensity score matching ....................................................................... 44
Outcomes ................................................................................................. 44
Statistical Analysis .......................................................................................... 45
Results ............................................................................................................. 48
Discussion ....................................................................................................... 52

iv

REFERENCES ....................................................................................................... 58

v

List of Tables

Table 1 ICD-9 Codes for comorbid conditions................................................................. 33
Table 2 ICD-10 codes for comorbid conditions ............................................................... 34
Table 3 ICD-10 and CPT codes for postoperative complications .................................... 35
Table 4 Demographics and characteristics of patients prior to propensity score matching
........................................................................................................................................... 48
Table 5 Demographics and characteristics of patients following propensity score
matching ............................................................................................................................ 49
Table 6 Parameter Estimates for Total Costs in the 90-day period following surgery ..... 50
Table 7 Parameter estimates and odds ratio estimates for any complication ................... 50

vi

List of Figures

Figure 1 Patient selection diagram .................................................................................... 29

vii

viii

CHAPTER I
INTRODUCTION
Osteoarthritis (OA) is an age-associated disease that affects millions of people in
the United States (WHO, 2010). According to the Centers for Disease Control and
Prevention (CDC, 2018). OA diagnosed by physicians will reach 25.9% of adults over
age 18 by 2040, nearly 78.4 million Americans.
The leading indication for OA is total joint arthroplasty (TJA) (Sloan &
Hanrahan, 2014; Kurtz, et. al., 2007). As the prevalence of OA continues to increase, so
will the need for TJA surgery. Shoulder osteoarthritis, in particular, and the resulting
treatment of total shoulder arthroplasty (TSA), has grown at a rate of 9.4% annually in
the United States and is projected to exceed that of total knee arthroplasty (TKA) and
total hip arthroplasty (THA) (Day et al., 2010). While TSA is largely performed on the
elderly, in the US it is increasing at a rate of 12.1% annually for those over the age of 55
years old. Furthermore, the procedure is also being used for younger people as well.
Between 2002-2011, the rate of increase in TSA for patients under 55 years old was 8.2%
in the US (Kim, Kim, Wise, Zhang, & Szabo, 2011; Padegimas, Maltenfort, Lazarus,
Ramsey, Williams, & Namdari, 2015).
Historically, TJA and TSA have proven to be safe procedures. Surgeons have
translated their good outcomes from inpatient TJA into the outpatient setting with good
results. These outcomes have motivated orthopedic surgeons to increase the use of TSA
in the outpatient setting as well (Berger et al., 2009; Courtney et al., 2016). As TSA has
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increased, researchers have evaluated its safety in the outpatient setting and found it to be
safe (Famer et al., 2007; Fehrigner et al., 2007).
In the outpatient setting, it is vital to avoid costly complications and readmissions.
Postoperative complications and unplanned hospital admissions following outpatient TJA
and TSA can increase costs following the procedure. In turn, this will decrease the value
associated with outpatient TSA. Healthcare providers need to be aware of patients that
are considered to be high-risk for complications following TSA and encourage those
patients to have surgery performed in an inpatient setting. Decreasing costly
complications will decrease the costs associated with inpatient TSA such as overnight
charges, hospital charges, nursing, labs, and medications (Crawford, Li, Sprague, &
Bhandari, 2015) In fact, Previous studies have shown the three major drivers for cost are
operating room costs, medical device costs, and length of stay in the hospital (Bosco, et
al., 2014; Healy et al., 1998; Healy et al., 1998; Raphael et al., 2014; Steinhaus et al.,
2018). While intraoperative costs, such as operating room time and surgical implants may
be common to both inpatient and outpatient TSA surgery, elimination of the inpatient
stay altogether can eliminate the third major cost driver— assuming the correct patients
are chosen for outpatient TSA.
Using protocols and care pathways to educate patients, identify high-risk patients
for complications, and redirecting those patients toward inpatient TSA is paramount to
successful implementation of outpatient TSA (Kim and Iorio, 2017; Brolin and
Throckmorton, 2018; Lombardi et al., 2016). These protocols and pathways will
encourage value by decreasing costs and improving outcomes by encouraging only high-
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risk patients to have their surgeries performed in the inpatient setting; low risk patients
would be encouraged to have their surgery performed in an outpatient setting, decreasing
costs. Moreover, it will create a perioperative environment promoting success by
following the aforementioned principles for outpatient TSA patients, thus decreasing
complications and unplanned hospital admissions. These complications and unplanned
hospital admissions following inpatient and outpatient TSA can be costly.
Healthcare spending in the United States is increasing dramatically and healthcare
leaders are looking for ways to decrease costs and encourage value. Current spending in
the US is nearly $3.5 trillion annually, or nearly 18% of the Gross Domestic Product
(Berland, Rocco & Walden, 2015; Bryan, 2016). Therefore, value is crucial to the future
to of our healthcare system. Value is defined as “health outcome per dollar of cost
expended” (Porter & Olmsted-Teidsberg, 2006, p.4). Therefore, healthcare experts are
focused on finding strategies to improve outcomes and decrease costs. According to
Porter & Olmstead-Teidsberg, they believe “the structure of healthcare delivery” is
essential to the success of our healthcare system (Porter & Olmstead-Teidsberg, 2006,
p.3).
As the volume of TJA and TSA increases in the United States healthcare leaders
are focused on value and the “structure of healthcare delivery” (Porter & OlmsteadTeidsberg, 2006, p.3). One option being discussed and studied by the Centers for
Medicare and Medicaid Services (CMS), to decrease the costs of TJA , is through the
Bundled Care Payment Initiative (BPCI). The BPCI process was designed to create value
for TJA by rewarding good outcomes and discouraging costly unnecessary care. This
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process will assist CMS in working to foster an environment where physicians, hospitals,
and post-acute care providers strive for interoperability and streamlining quality care to
these patients. As TJA is considered a costly procedure, this program is designed to
increase productivity, drive down costs, and increase value associated with the
procedures (CMS, 2018).
As researchers continue to investigate BPCI as a cost-saving strategy for TJA,
outpatient TJA and TSA have become more popular. Approximately 60% of all surgeries
done in the United States in 2011 were outpatient (ASCA, 2011). Further, outpatient TJA
has been shown to be cost-effective in the past (Aynardi et al., 2014; Crawford, Li,
Sprague & Bhandari, 2015; Lovald et al., 2014). This research has provided the
motivation to demonstrate the cost effectiveness of inpatient TSA (Crawford et al., 2015;
Mather et al., 2015). As inpatient TSA costs could vary from $1500-$12,500 per day,
these costs could be completely avoided by utilizing outpatient TSA (Steinhaus et al.,
2018).
TJA is the largest procedural consumer of Medicare’s budget at 6.3% annually
(Dobson et al., 2012). Outpatient TSA is one way to decrease these costs and increase
value for consumers to ensure the solvency of the US healthcare system. To date, there
has been little work focused on comparing outpatient TSA versus inpatient TSA and the
potential cost savings. This study will ameliorate this problem by selecting only patients
in both inpatient and outpatient settings who could genuinely have their surgery done in
the outpatient setting; as all of the patients in this study are not high risk.
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This study has been designed to determine the marginal cost differences of total
shoulder arthroplasty performed in an outpatient setting compared with that same
procedure performed in an inpatient setting in a well matched group of low to medium
risk patients, with the following aims:
Aim 1
To determine if outpatient total shoulder arthroplasty offers a cost advantage over
the inpatient setting among patients with similar preoperative risk and treatment.
Aim 2
To determine the demographics of inpatient total shoulder arthroplasty versus
total shoulder arthroplasty in an ambulatory surgery center and outpatient surgery.
Rationale of Importance
As value is becoming increasingly important, healthcare leaders must continue to
seek out and find ways to balance cost savings with uncompromising patient safety.
Outpatient TSA should not be an option for every patient; likewise, inpatient TSA should
not be a consideration for every patient. Healthcare providers and patients need to be
responsible enough to avoid costly errors by treating those patients with significant
medical risks as inpatient. However, providers and patients should also encourage value
by facilitating outpatient TSA for those patients who qualify. As our population ages,
increasing numbers of people will develop osteoarthritis, resulting in increased need for
TSA, which will drive up healthcare costs. Therefore, healthcare leaders should strive to
ensure this procedure is delivered in the most cost-effective manner.

CHAPTER II
REVIEW OF THE LITERATURE
Population & Osteoarthritis
The United States population is aging and by 2050 there will be a substantial growth of
Americans over 65 years old. The baby boomers have contributed to the increase in elderly
Americans as those over the age of the 65 are estimated to be 83.7 million (Ortman,Velkoff, &
Hogan, 2014). As this aging of America’s population occurs, there will also be an increase in
age-associated pathologies. Healthcare experts will need to be aware of these changes and
equipped to handle them.
One such age-associated disease is osteoarthritis (OA). Osteoarthritis is the sixth leading
cause of years lived with disability (YLD) in the world (WHO, 2010). According to the Centers
for Disease Control (CDC, 2018), there are approximately 54.4 million adults in the United
States who have been diagnosed with OA, which is approximately 22.7% of the US population.
Furthermore, nearly 43.5% of those with the diagnosis of OA admit to limitations of their daily
activities associated with the disease. This could contribute to decreased activity levels and
encourage other diseases such as obesity, diabetes, and cardiovascular disease. The CDC
estimates that doctor-diagnosed OA to reach 25.9% of adults over the age of 18 by 2040,
equaling approximately 78.4 million Americans (Ibid).
Total Joint Arthroplasty & Volume
Currently, OA is the leading indication for total joint arthroplasty (TJA) (Kim et al.,
2011). As a result, the numbers of the TJAs performed have grown tremendously. Between 2005
and 2030, total hip arthroplasties are expected to increase 174% and total knee arthroplasties
673%. As a result, the number of TJAs will increase by an expected 3,480,000 total knee
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arthroplasties and 572,000 total hip arthroplasties in the United States per year by 2030 (Sloan &
Hanrahan, 2014; Kurtz, et. al., 2007). According to the Organisation for Economic Co-operation
and Development knee replacements grew by 50% (143 to 213 TKA per 100,000 people in the
US ) in 2017 and hip replacements grew by 35% (185 to 226 people per 100,000 people in the
US) followed closely at 35% (OECD, 2018; Lam, et al., 2018).
Total Shoulder Arthroplasty & Volume
The primary reason for total shoulder arthroplasty is osteoarthritis. Therefore, total
shoulder arthroplasty (TSA) is increasing at a fast rate with a growth of 9.4% annually in the US
and projections are exceeding those of lower extremity arthroplasty (Day et al., 2010; Kim et al.,
2011). Day et al. (2010) found procedural volumes increasing 6 to13% in annually from 19931997; and from 2007-2015 increases in projected annual rates were projected to increase 192 to
322%. These increases will necessarily increase the revision burden of TSA, as well. Kim et al.,
(2011) showed two-thirds of the TSAs performed in the US were performed on the elderly (65
years and older).
Researchers have shown an increase in TSA 3.5 times higher than before 2000 (Kim et
al., 2011). There are at least five reasons for this increase in TSA. First, Kim et al. (2011)
suggest it could be a result of the introduction of the reverse total shoulder arthroplasty (RTSA).
The RTSA could have provided a correction in the numbers secondary to treating rotator cuff
arthropathies, not normally treated by anatomic TSA. Prior to the RTSA, patients with rotator
cuff arthropathies would undergo a hemiarthroplasty or forgo surgery. Second, there is likely a
growing acceptance, or mainstreaming, of TSA secondary to its increase use and success. This
acceptance will lead to more training programs, resulting in more specialty trained shoulder
surgeons. Third, an increase in medical device companies has improved implant design. Fourth,
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improvement in perioperative pain control has also increased the ability of surgeons to do more
volume. Better methods of pain control will encourage successful TSA procedures and motivate
other patients to have the procedure (Brolin & Throckmorton, 2018). Fifth, and finally, the
percentage of the elderly in the US is rising—which is the group that undergoes the most TSAs
(Kim, et al., 2011).
The demand for TSA is growing among other demographics as well. There has also been
an increase in the demand for TSA in younger patients. Padegimas et al. (2015) evaluated the
demand for those patients younger than 55 years old between 2002-2011. The rate of TSA
increased 8.2% annually among those under the age of 55 years old and 12.1% for patients over
55 years old. Further, overall from 2002 to 2011, their research suggested an increase of 755.4%
in TSA within this demographic. However, they noted the need for TSA in younger patients less
than 55 years old will triple between 2011-2030 (Padegimas et al., 2015).
Safety of Total Joint Arthroplasty
Historically, authors have used evidence from total knee arthroplasty (TKA) and total hip
arthroplasty (THA) to explain the importance of examining TSA. Researchers have used studies
to prove the safety of TJA. Successful approaches to total knee arthroplasty (TKA) and total hip
arthroplasty (THA) have provided the impetus for ambulatory TSA. Past studies have shown
TJA to be safe.
Berger, Sanders, Sporer, & Della Valle (2009) and Berger, Kusuma, Sanders, Thill, &
Sporer, S. M. (2009). demonstrated in two separate studies the safety and efficacy of outpatient
total hip and total knee arthroplasties. Additionally, Courtney et al. (2016) conducted a database
analysis of patients receiving THA and TKA between 2011-2014. The authors propensity score
matched outpatient and inpatient cohorts and found the complication rates for outpatient TJA 8%
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versus inpatient 16%. Lovald et al. (2014) evaluated short stay TKA and found a lower
complication and readmission rate for those undergoing an outpatient or 1-2 days stay following
TKA. The patients in this group also showed lower Charlson morbidity scores and tended to be
healthier than those patients staying the standard 3-4 nights inpatient. However, not all studies
have shown a reduction in readmissions following outpatient TJA. Springer et al (2016)
evaluated TKA and THA from 2010-2011 and found inpatient TJA to have lower readmission
rates than outpatient. While the numbers were not statistically significant, the outpatient TJA
readmission rate was 11.7% compared to the inpatient at 6.6% (Springer et al., 2016)
Additionally, Springer et al. (2016) emphasizes the importance of identifying those morbidities
increasing the rate of adverse events, complications, and readmissions following TSA.
Total Shoulder Arthroplasty & Complication Risk Factors
Previous studies in TJA have shown certain demographics and morbidities associated
with increased complications. Patients with a history of smoking, cardiac disease, diabetes,
malnutrition, and patients greater than 70 years old were at higher risk and this was statistically
significant (Courtney et al., 2017).
Recognizing risk factors for complications and hospital readmissions to the hospital will
prevent associated unnecessary costs. Dunn et al. (2015) conducted a retrospective analysis of
2004 patients between 2005 and 2011, to evaluate predictors of length of stay (LOS) after TSA.
These patients had an average age of 68.8 years, with an average LOS for these patients was 2.2
days. They identified several risk factors for increased postoperative length of stay
postoperatively: renal insufficiency, it looks like in well matched groups between inpatient and
outpatient the length of stay was similar cardiac disease, advanced age (>65 years old), American
Society of Anesthesiologists Class 3 or greater, females, and increased operating room times
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(Dunn et al., 2015). Controlling for these risk factors during preoperative assessment by treating
other medical comorbidities could decrease length of stay. Further, educating patients prior to
surgery is paramount as proper education will inform the patients regarding potential risks and
could prevent return to the ED.
Basques et al. (2017) compared outcomes of patients undergoing TSA inpatient versus
outpatient. They retrospectively analyzed 123,347 Medicare patients between 2005-2012,
matching age, gender, and medical morbidities. Overall, they found outpatient TSA was safer
among younger and healthier patients: The outpatient cohort demonstrated a lower 30 and 90day readmission rate and complication rates compared to the inpatient cohort. Among those in
the inpatient cohort, the authors identified a higher percentage of women, and higher rates of
smoking, diabetes, coronary artery disease, congestive heart failure, and chronic kidney disease.
Moreover, complications were also higher in this group including thromboembolic events and
surgical site infections. In all, this article indicates patients who had a TSA in an outpatient
setting tended to be healthier and younger, whereas those patients who had a TSA in an inpatient
setting tended to have increased medical morbidity and higher rates of complications.
The findings from Cancienne et al. (2017) supported the other studies by showing the
importance of selecting appropriate patients for ambulatory TSA. The authors looked at 706
patients who underwent ambulatory TSA nationwide. The patients were propensity score
matched to 4,459 inpatient TSAs. The authors analyzed numerous demographic variables and
risk factors for readmission including age, sex, diabetes, tobacco use, chronic kidney disease,
coronary artery disease, Charlson Comorbidity Index (CCI), chronic anemia, and obesity. The
authors found no differences in complication rates when comparing the cohorts. Moreover, there
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was no difference in the rate of readmission in the 90 days following surgery. As a result, the
authors noted the importance of choosing appropriate patients for ambulatory surgery.
Identifying risk factors for complications and readmission is important in order to reduce
costs associated with TSA. Developing methods to identify risk factors and prevent readmissions
is equally important. One method is utilizing protocols and care pathways.
Outpatient Total Shoulder Arthroplasty & Safety
As outpatient TSA becomes more common, we must be cognizant of ways to increase
safety and improve outcomes. Researchers have evaluated TSA, and comparing it to TKA and
THA and have found it to also be safe in an inpatient setting. Famer et al., (2007) analyzed
34,471 inpatient TKAs, 994 inpatient TSAs, and 15,414 inpatient THAs and the complication
rate for TSAs was just 7.6%, whereas the rates among THA was15.5% and TKA 14.7%.
Fehringer et al. (2007) completed a study of the Veteran’s Administration showing a 30-day
complication rate of only 2.8% for inpatient TSA patients compared to 6.8% inpatient TKA and
7.6%, inpatient THA. Brolin et al., (2017) demonstrated in a small cohort of 30 patients the
average length of stay (LOS) for TSA patients was approximately 1.1 days. These studies
support the safety and success of inpatient TSA vs. TJA.
Waterman et al. (2015) evaluated TSA and its morbidity and mortality for 30 days
following the procedure. The mortality was 0.25% while the complication rate was 3.64%.
Peripheral vascular disease significantly increased the risk of complications as well as longer
operating room times. Thus, decreasing length of stay at hospitals and choosing to utilize
ambulatory TSA has been shown to be safe and effective.
Farng et al. (2011) showed short term complication rates are very similar to those of long
term complications. Mortality rate was low at 1.3%. Further, they found the risk of complication
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was higher in those patients receiving a hemiarthroplasty secondary to a fracture compared to
primary anatomic TSA for osteoarthritis. The difference in these cohorts could be explained by
the medical comorbidities. Fractures are less likely to be elective procedures, while primary
TSAs are elective surgeries requiring more medical screening, thus decreasing the likelihood of
complications following surgery.
Decreasing complications and readmissions is important to reduce costs. Duchman et al.
(2017) showed a lower rate of postoperative complications between outpatient TSA and inpatient
TSA cohorts. The researchers found a complication rate of 1.8% versus 5.0% for the outpatient
and inpatient cohorts, respectively. However, the short stay patients (discharged on postoperative
day 0 to 1) were younger with an average age of 67.6 years . Further, the short stay patients were
less likely to having medical comorbidities associated with complications and readmissions such
as coronary artery disease, diabetes, obesity, and chronic obstructive pulmonary disease (COPD).
Likewise, Nwankwo et al. (2018) evaluated the 90-day risk of complications for patients
receiving outpatient TSA versus inpatient TSA. After propensity score matching on baseline
characteristics, their results were statistically significant, as they found no differences in rates of
readmission, emergency department visits, morbidity within 90 days of surgery or mortality
(Nwankwo et al., 2018).
After propensity score matching patient demographics, Leroux et al. (2016) compared
outpatient to inpatient TSAs, finding the 30-day readmission rate for outpatient TSA to be 1.74%
compared to the inpatient 2.93% among patients in an inpatient setting. Moreover, the 30-day
adverse event rate was even more impressive the outpatient cohort adverse rate was 2.31%
compared to the inpatient cohort’s 7.89%. They showed no difference in readmission rate or
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adverse event rates for outpatient versus inpatient TSA, yet the numbers were not statistically
significant.
Brolin et al. (2017) propensity score matched age and comorbidities in a small cohort of
30 patients comparing inpatient and outpatient TSA patients. The authors evaluated a 90-day
time frame monitoring the patients’ care--including readmissions, reoperations, and
complications. Twenty-seven of the 30 patients were sent home postoperatively on day 1. The
remaining three patients were sent home the following day. The average length of stay for the
inpatient cohort was (1.1) days. No significant differences between inpatient and outpatient
cohorts were found for age, body mass index, and American Society of Anesthesiologists (ASA)
scores. The complication rates were not statistically different, with 10% versus 13% for
outpatient TSA versus inpatient TSA, respectively.
Avoiding costly complications and readmissions will encourage the implementation of
outpatient TSA. Identifying risk factors associated with complications and readmissions to the
hospital following TSA is paramount.
Outpatient Total Joint Arthroplasty – Protocols & Pathways
Pathways and protocols are helpful to identify high-risk patients to both prevent
postoperative complications and to choose the ideal surgical setting — whether inpatient or
outpatient. Moreover, these pathways could provide a means to avoid readmissions and
complications, thus decreasing costs, securing good outcomes, and ultimately increasing value.
The most common demographic for outpatient surgery centers is adult females 45-60
years of age (Cullen, Hall, & Golosinskiy, 2009). While risk factors for complications are likely
lower in this demographic, patient selection is vitally important for successful implementation of
outpatient TSA. Utilizing pathways and specialized protocols to identify patients at risk for

14
complications prior to elective anatomic TSA are vital to prevent postoperative complications.
Outpatient TSA requires healthcare professionals to properly evaluate those patients and direct
at-risk patients to inpatient settings. In turn, this redirection of at-risk patients will decrease the
risk of potential complications and decrease costs. There is a correlation between preoperative
medical morbidities and post-operative complications (Chalmers et al., 2014).
Lovett-Carter et al. (2018) and Berger et al. (2009) noted the safety of outpatient TJA
(TKA and THA) and recommended the use of pathways and protocols to identify high-risk
patients and prevent postoperative complications. Using these standardized protocols and
pathways requires a multidisciplinary approach for those patients to be successful. Otherwise,
these patients could be at a higher risk for readmission or visits to the emergency department.
Chalmers et al. conducted a retrospective review of patients receiving a primary anatomic
TSA and the complication rate for these patients was 9.4% at 90 days postoperatively. In this
study, the Charlson Comorbidity Index (CCI) demonstrated are complication rates and TSA
(p<.05). Thus, surgeons should use the comorbidities represented in CCI to help them predict
potential complications and those patient with higher CCI should be directed toward inpatient
TSA.
Three separate articles have provided insight into protocols and pathways. First, while
studying Bundled Payment Care Initiative (BPCI), Kim and Iorio (2017) provided five clinical
pillars for success to reduce complications and cost drivers.
1. Optimize patient selection and comorbidities
The researchers noted that medical comorbidities can increase the risk for complications
perioperatively. Kiridly et. al. (2014) observed that in their own facility, the most common
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of these medical problems included hypertension, hyperlipidemia, tobacco use, and
diabetes.
2. Optimize Care Coordination/Patient Education/Expectations
Parties can mitigate potential risks by educating patients regarding the potential risks
associated with the procedure, in relation to their own medical comorbidities, and by
streamlining the various pathways based on each patient, this will mitigate the potential
risks for complications. Providing standardized care plans and promoting provider to patient
and intra-provider communication has been shown to foster value-driven care. Kim and
Iorio (2017) noted their institutional goals have been to encourage “collaborative decisionmaking” amongst the providers and to streamline the process by maintaining more than
80% of the standardized care to remain in their care pathways (p. 1714).
3. Multimodal analgesia for TJA
Analgesic techniques such as administration of NSAIDs, opioids, nerve blocks, and
liposomal bupivacaine accelerate the postoperative process by encouraging early range of
motion, mobilization, and physical therapy. Of course, each of these techniques promotes
an earlier recovery by the patient, decreases the likelihood of complications related to the
TJA, and decreases length of stay.
4. Risk-stratified VTED prophylaxis
Any lower extremity surgery has increased the risk of venous thrombosis embolism (VTE).
Considered a complication of TJA, VTE requires rehospitalization, thus increasing the
postoperative costs of TJA. Currently, there are different forms of VTE prophylaxis
including aspirin, Coumadin, low-molecular weight heparin, sequential pneumatic
compression devices, and compression stockings. These therapies coupled with early
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mobilization can discourage the development of VTE. As noted earlier, it is important to
consider each patient individually, and encourage those patients to follow the care pathway
or algorithm (Kim & Iorio, 2017).
5. Minimize Post-Acute Facility and Resource Utilization
Admitting a patient to a skilled-nursing facility or other post-acute rehabilitation facilities
can be quite costly to our healthcare system. Furthermore, extended stays in these types of
facilities could increase one’s risks of complications such as infection and VTE, will further
increase costs. Utilizing a multidisciplinary collaborative approach to TJA patients
preoperatively, intraoperatively, and postoperatively is a necessity to avoid expensive
readmissions. Each member of the team needs to be functioning under the same goals, thus
encouraging quality and value-based care (Kim & Iorio, 2017).
The second important article that helps us to understand clinical protocols and pathways
is Brolin and Throckmorton (2018). This article helps affirm these pillars by noting the
importance of the following:
1. patient selection
2. pain management
3. limiting intraoperative blood loss
4.

patient education.
Lastly, Lombardi et al. (2016) provided their care pathway as the “Ten Steps for

Successful Execution of Outpatient Arthroplasty” as follows:
1. Orthopaedic assessment
1. Preoperative medical clearance
2. Preoperative education
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3. Preoperative physical therapy
4. Preoperative analgesic agents
5. Perioperative anesthetic agents
6. Efficient performance of the surgical procedure
7. Wound healing adjuncts
8. Establishment of clinical pathways
9. Explicit post discharge instructions
Each of these articles provided by Kim and Iorio (2017), Brolin and Throckmorton
(2018), Lombardi et al. (2016) emphasizes the importance of patient selection. This patient
selection includes avoiding those patients who would increase the risk of complications and
readmissions. As unplanned admissions are being more heavily scrutinized by Centers for
Medicare and Medicaid Services (CMS) and insurance companies and Bundled Payments for
Care Improvement Initiative (BCPI) gains momentum, the aforementioned protocols and
programs will become increasingly important. Following the aforementioned protocols will
enable healthcare providers to provide the best evidence-based care possible while limiting
wasteful spending. Outpatient TSA could potentially reduce length of stay and the additional
secondary costs associated with a longer length of stay. Utilizing the aforementioned pathways
and protocols could assist in this reduction and encourage outpatient TSA as a value-driven
option compared to inpatient TSA.
Total Joint Arthroplasty & Costs
In the United States, healthcare spending is nearly $3.5 trillion annually, which is
nearly18% of the Gross Domestic Product (GDP); on average this is approximately $9990 per
person (Berland, Rocco & Walden, 2015; Bryan, 2016). There has been considerable attention
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focused upon the costs of TJA its cost; at 6.3%, it is the largest procedural consumer of
Medicare’s budget (Dobson et. al., 2012). As a result, healthcare leaders have been seeking
strategies to decrease expenses associated with total joint arthroplasty.
Historically, there has been plenty of research evaluating costs savings associated with
performing outpatient TKAs and THAs in outpatient versus inpatient settings. Typically, these
studies find cost savings in performing these procedures in outpatient settings. For instance,
Aynardi et al. (2014) showed a cost reduction in outpatient THA compared to inpatient, $24,529
versus $31,327, respectively (p=0.0001). Lovald et al. (2014) examined the costs of ambulatory
TKA demonstrating an average costs savings of $8,527 per patient. Other researchers in a
systematic review showed multiple procedures with a costs savings ranging from 17.6% to
57.6% decrease for outpatient surgical procedures (Crawford, Li, Sprague & Bhandari, 2015).
Improving outcomes, decreasing costs, and consequently increasing value is vital to the
solvency of our healthcare system. We must train our healthcare providers to be cost-conscious
and value-driven during their education. This training will instill a culture of value and
sustainability necessary for innovative procedures such as outpatient total joint arthroplasty.
Bundled Care Payment Initiative (BCPI)
One option currently being discussed and studied to decrease costs for TJA is the
Bundled Care Payment Initiative (BPCI). One subprogram of the BPCI is the conference of care
for joint replacement model (CJR). In 2016, CMS began a pilot program that would last for 5
years and using 67 different areas around the country, known as Metropolitan Statistical Areas
(MSAs; urban center with a population of 50,000 or greater)(CMS, 2018). These areas are urban
centers with a population of 50,000 or greater. Prior to implementation, CMS collected data
online for 2 months from citizens regarding the program and used this data to make changes to
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the program. This model is known as the Comprehensive Care for Joint Replacement Model
(CJR) and will serve as a CMS pilot for bundling total hip and knee arthroplasties, while
attempting to create more efficiency with total knee and total hip arthroplasties. These
procedures, defined by CMS as lower extremity joint replacements, are known as the costliest inpatient procedures for CMS. This pilot is responsible for evaluating each episode of care and
testing the efficiency and quality of the bundled payment. During this process, CMS will work to
foster an environment where physicians, hospitals, and post-acute care providers strive for
interoperability and streamlining quality care to these patients. This model is expected to
increase productivity, drive down costs, and increase value associated with the procedures
(CMS, 2018).
The CJR model promotes a value-driven paradigm by incentivizing each stakeholder
involved in the TJA episode of care through TJA increasing financial accountability,
encouraging quality care, and fostering coordination amongst stakeholders (CMS, 2018).
Patients will promote a value-driven paradigm. Beneficiaries begin their episode of care by being
admitted to the hospital; this begins a 90-day period on the day of admission. These patients
must have been seen for major joint replacement of the lower extremity, defined as having their
stay coded under one of the following diagnosis-related groups (MS-DRG) (CMS, 2018):
•

MS-DRG 469 – major joint replacement or reattachment of lower extremity with major
complications or comorbidities, or

•

MS-DRG 470 – major joint replacement or reattachment of lower extremity without
major complications or comorbidities

In the CJR model, each episode includes all services or devices paid for under Medicare Part A
or B. During the pilot program, the performance of each hospital and its pricing goals for costs

20
related to the stated DRGs will be evaluated annually. Target pricing will be compared to actual
pricing and CMS will evaluate performances setting new reimbursement goals for the hospitals.
CMS will employ a performance-based analysis of sort; if the hospital is under its expense goal,
then they could be reimbursed the difference. However, if they exceed the stated expense goals,
they could be forced to repay some of their expenses. During this 90-day global period, any
complications or readmissions related to surgery will drive the costs upward and decrease any
profits realized under the bundled payment, as the hospital and physician could be responsible
for the costs (CMS, 2018). This additional cost could be especially pertinent to outpatient TJA.
Patients released from ambulatory surgery centers or hospitals postoperatively could visit the
emergency department, or even be admitted to the hospital, due to surgical complication, thus
increasing costs. Moreover, patients could possibly be admitted to the hospital, thus increasing
costs. This cost increase could be a potential large loss of revenue for the stakeholders--the
outpatient surgery center, hospital, and provider--if outpatient TJA is not implemented
appropriately by correctly choosing the most appropriate patients.
Previous studies have shown there are three major cost drivers for surgery: operating
room costs, medical device costs, and length of stay in the hospital (Bosco, et al., 2014; Healy
eta al., 1998a; Healy et al., 1998b; Raphael et al., 2014; Steinhaus et al., 2018). As a result,
programs like BPCI encourage surgeons to focus on patient selection, medical comorbidities, and
directing appropriate patients who qualify toward an outpatient setting for surgical care, there
could be potential cost savings. By minimizing length of stay and directing qualified patients
toward outpatient settings, there could be potential cost savings. However, no study to date has
investigated if cost savings are possible among patients undergoing TSA in an outpatient setting
versus those in an inpatient setting, among those who are well matched for potential risk factors.
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Outpatient Total Shoulder Arthroplasty– Costs & Value
As the healthcare environment continues to change, resources are becoming limited and
increasing value is permanently at the forefront of this change. As greater emphasis is placed on
achieving high quality outcomes while also containing costs, value becomes increasingly
important. According to Porter and Olmstead-Teidsberg (2006), strategically healthcare can be
divided into three categories: “cost of and access to health insurance, standards for coverage or
the types of care that should be covered by insurance versus being the responsibility of the
individual, and the structure of healthcare delivery itself” (p.3). They believe the structure of
healthcare delivery is essential to the success of our healthcare system (Porter & OlmsteadTeidsberg, 2006). Competition and quality are very important in the free market and there is
great emphasis placed on value. In healthcare, this translates to “health outcome per dollar of
cost expended” (Porter & Olmsted-Teidsberg, 2006, p.4).
Thus, decreasing healthcare expenditures is vital to the solvency of our healthcare
system. Furthermore, all things being equal for similar health outcomes and similar rates of
complications, that given two options for treatment the low cost option is the one with greater
value.
Outpatient TSA and TJA are part of a general trend in healthcare, increasing focus on the
patient, decreasing unnecessary medical procedures, thus increasing value (Lombardi et al.,
2016). According to the Ambulatory Surgery Association (ASCA) approximately 60% of all
surgeries performed in 2011 were done in an outpatient setting (ASCA, 2011). The increase in
outpatient TJA and TSA could represent a response to the CMS and BPCI. As healthcare
providers strive for cost containment and value, they will be motivated to potentially increase
outpatient surgery. Further, if CMS were to increase coverage to outpatient surgery centers, this
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might incentivize providers to utilize surgery centers for TSA, yielding cost savings. By
decreasing the length of stay, other downstream cost drivers will decrease such as overnight
hospital charges, nursing, therapy, labs, medications, and other studies, and consequently, overall
costs will go down (Crawford et al., 2015). This is where real cost savings are realized through
TSAs performed in an outpatient setting.
While there is little research evaluating the differential costs of outpatient TSA, there is
ample research evaluating the costs associated with the conditions necessitating TSA. Shoulder
pathology rates are increasing and so are costs associated with them. In 2006, the costs for
musculoskeletal diseases was 4.5% of GDP or $576 billion. Patients complaining of chronic
shoulder conditions represented 8.2% of the US population or 18.9 million adults (AAOS, 2011;
CMS, 2011). Current literature suggests there are approximately 39,000 TSAs performed
annually (Day et al., 2015; Kim et al., 2011; Ponce et al., 2015). Cost estimates for a TSA vary
widely, from $14,000 to $52,000 per patient, with the average 4-year total cost at $17,587 (Ponce
et al., 2015; Verani et al., 2013; Davis et al., 2014). Thus, the total annual costs of TSAs in the
United States range from $490 million to $1.8 trillion. (Ponce et al., 2015; Verani et al., 2013;
Davis et al., 2014).
Total Shoulder Arthroplasty & Cost Savings
Research has proven outpatient orthopedic procedures to be cost-effective. Crawford et
al. (2015) performed a systematic review of the literature evaluating outpatient orthopedic
procedures and found an average cost savings of 17.6 - 56.6%. Furthermore, research has shown
TSAs and hemiarthroplasties to be cost-effective also. Mather et al. (2011) conducted a costutility analysis of TSA and hemiarthroplasty, finding TSA to be a cost-effective procedure.
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Although inpatient TSA has been shown to be cost-effective, it is still a costly procedure.
Eliminating costs associated with inpatient procedures could decrease costs and increase value.
Inpatient admission costs, after a TSA, could vary from $1500 - $12,500 per day (Steinhaus et al.
2018). Steinhaus et al. (2018) created a model to estimate cost savings for performing TSAs in
an outpatient setting, instead of in an inpatient setting, by looking at the literature, estimating a
cost savings of between $747 and $15,507 per outpatient TSA is likely. They extrapolated this
out to an annual cost savings ranging from $4 to $349 million, with a potential 10-year potential
savings for outpatient TSA between $51 million to $5.4 billion (Ibid.).
To date, there has been only one study which directly evaluated the costs associated with
outpatient TSA and comparing those costs to the costs of inpatient TSA. The one study which do
so was conducted by Cancienne et al. (2017), who performed a retrospective analysis of 4,459
propensity score matched patients receiving outpatient TSAs to compare the costs of those
undergoing the procedure in an outpatient versus inpatient setting, using with ICD-9 codes. The
authors excluded reverse total shoulder arthroplasty, acute proximal humerus fractures, and
osteonecrosis of the proximal humerus. They found for those matched patients undergoing
outpatient TSA there was a cost savings, as the median cost was $14,722 for outpatient and
$18,336 for inpatient, controlling for the following: sex, 10-year age group, tobacco use, obesity,
chronic kidney disease, coronary artery disease, chronic anemia, and diabetes. This amounts to a
cost savings of $3,614 per case, which is a 19.7% cost reduction over having the surgery done in
an inpatient setting.
There were no differences in outpatient TSA and inpatient TSA while comparing all
postoperative complications (p.<.05). The control group had a lower rate of urinary tract
infection (6.8 <8.7%) (p<0.003) and blood transfusions (3.5%<4.7%) (p<0.028). Overall the
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control group had a higher rate of medical and systemic complications postoperatively at 90 days
(15.9%,17.7%) (p<0.012). The risk factors for readmission following outpatient TSA in this
study were peripheral vascular disease (OR, 1.7; 95% CI: 1.14-2.66, p=0.025), diabetes (OR, 1.5;
95% CI: 1.17-1.98, p=0.025), chronic lung disease (OR, 1.8; 95% CI: 1.09-2.88, p=0.021),
congestive heart failure (OR, 2.0; 95% CI: 1.16-3.52, p=0.014), depression (OR, 2.4; 95% CI:
1.54-3.80, p<0.0001), and chronic anemia (OR, 2.2; 95% CI: 1.36-3.47, p=0.001). There were a
multitude of risk factors for readmission for inpatient TSA. The risk factors were similar to the
outpatient findings, including greater than 80 years old.
The limitations of this study relate to the use of large database analyses. First, the
accuracy the information and the quality of the reporting in the database. Second, certainly, there
is some degree of selection bias in selecting younger and healthier patient for outpatient TSA.
Third, there are some regional inconsistencies in reimbursement rates across the US, thus
affecting some of the cost analyses. However, this study also had some strengths. First, used a
large database for privately insured and Medicare patients. Second, the study included a large
cohort of 4,459 propensity score matched patients. Third, the study covered from 2010 to 2014,
providing a good time frame. Fourth, the authors appropriately matched both groups and used
multivariate regression to analyze the data. Overall, this was a well-designed study with reliable
and valid results.
Currently, Cancienne et al.(2017) is the only published study comparing costs of
outpatient versus inpatient TSA. The study was performed shortly after the implementation of
the Affordable Care Act and was utilizing ICD-9 data from 2010 through 2014, prior to the
implementation of ICD-10. Using ICD-10 data will help identify more detailed data related to
the outpatient and inpatient TSA. For example, ICD-9 data does not identify laterality, while
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laterality is built into ICD-10 data. The present research need is to understand the differential
costs between TSAs performed in an outpatient versus inpatient setting. Secondarily, an
examination of the rates of complications between these two surgical settings to ensure
equivalent quality across these two settings still exists, or if one setting is superior to another.
Further, this research will assist future healthcare providers in determining whether outpatient
TSA is indeed less costly than inpatient TSA. Yet, there should be more effort in evaluating the
cost of outpatient TSA with ICD-10 in lieu of the Affordable Care Act and if its less costly than
inpatient TSA. This will become increasingly important with BPCI and increased interest in
value-driven care. Stakeholders in TSA, such as orthopedic surgeons, hospitals, and insurance
companies each share an interest in the results of BPCI and potential value of outpatient TSA as
a means of cost savings and increased profits.

CHAPTER III
METHODOLOGY
Specific Aims and Hypotheses
This study’s research hypotheses were designed to explore costs after total
shoulder arthroplasty and provide information germane to outpatient versus inpatient
TSA. and those variables that account for differences in costs. Expressly, the research
hypotheses were developed to discover which setting for TSA showed higher costs,
inpatient, ambulatory, or outpatient TSA. Outpatient TSAs are those procedures that are
done at the hospital and the patient is discharged to home the same day. Ambulatory
TSAs are those procedures done in an ambulatory surgery center. Lastly, inpatient TSAs
are those procedures done in a hospital and the patient remains 24 hours. Between these
setting, we will examine the HIM distribution for each of these procedures. Furthermore,
which comorbidities create the highest risk for costly complications and readmissions
following TSA. Therefore, there is increased risk for selection bias. Choosing patients to
undergo outpatient TSA requires choosing those patients who are healthy and are likely
to be privately insured. The propensity-score matching will be used to match these
patients and account for this bias.
Aim 1
To compare the safety of outpatient versus inpatient total shoulder arthroplasty among
patients with similar preoperative risk.
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Hypothesis 1 (H1): Patients who undergo total shoulder arthroplasty in an
outpatient setting will have lower complication rates than those in an inpatient
setting.
Hypothesis 2 (H2): Patients who undergo total shoulder arthroplasty in an
outpatient setting will have lower readmission rates than those in an inpatient
setting.
Aim 2
To determine if outpatient total shoulder arthroplasty offers a cost advantage over the
inpatient setting among patients with similar preoperative risk.
Hypothesis 3 (H3): Patients who undergo total shoulder arthroplasty in an
outpatient setting will have lower costs than those in an inpatient setting.
Study Design
A retrospective analysis of archival billing for patients undergoing total shoulder
arthroplasty (TSA) will be conducted to analyze administrative data for cost and safety
differences between TSAs performed an inpatient versus outpatient setting. The primary
aim of the study is to compare cost for well-matched groups of patients receiving TSA in
outpatient and inpatient settings.
Baseline characteristics will be comparably matched and variables influential to
the costs associated with TSA such as sex, age, comorbidities, complications, and
readmissions were also measured. Using a 1:1 propensity score matching ratio will
provide the necessary balance for covariates in the study (Hanna et al., 2008). Accurately
assessing and rejecting the null hypothesis for another hypothesis and the probability of
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this occurring, shows the power of a study (Shi, 2008). Relationships between the
aforementioned variables will be analyzed. The secondary aim of this study will be to
analyze those variables that significantly contribute to the cost of TSA.
Population and Sample
All inpatient discharges from selected states with an index admission for a total
shoulder arthroplasty (TSA) were used for analysis. Archival data were obtained from
Medicare 5% limited data set and MarketScan privately insured billing data from 2016.
The data were deidentified. The Medical University of South Carolina (MUSC)
Institutional Review Board has previously classified studies that use these data as nonhuman research.
This study utilizes the Centers for Medicare and Medicaid services (CMS)
definition for elective anatomic total shoulder arthroplasty, which is defined as having a
CPT code of 23472 or ICD-10 PCS procedure Z96.611 (left/right TSA) or Z96.612—
which is part of Diagnostic Related Group (MS-DRG v35.0) in 2016. This cohort will
include all patients who received an anatomic TSA during 2016 and will have a 6 month
pre-index period and a 12 month post-index utilizing private insurance, Medicare, and
Medicaid. Patients who underwent reverse TSA (RTSA) and hemiarthroplasty will be
excluded from the study as these patient populations can be different than those seeking
elective anatomic TSA secondary for osteoarthritis.
Patients will be excluded if they meet any of the following exclusion criteria:
Patients with the diagnosis of acute proximal humerus fracture (S42.201A) or
osteonecrosis (M87.811) of the proximal humerus.
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Figure 1 Patient selection diagram
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Database
Two databases will used for data analysis in this project. Patients aged 55-64 will
be extracted from the Truven Health MarketScan® Commercial Claims And Encounters
(CCAE) database. Patients aged 65-74 will be extracted from the MarketScan® Medicare
supplemental insurance database. Below is a description of these databases from the
Truven Health MarketScan® Analytics Commercial Claims and Encounters Medicare
Supplemental User Guide Data Year 2015 Edition.
The Truven Health MarketScan® Research Databases capture person-specific
clinical utilization, expenditures, and enrollment across inpatient, outpatient,
prescription drug, and carve-out services. The data come from a selection of
large employers, health plans, and government and public organizations. The
MarketScan® Research Databases link paid claims and encounter data to detailed
patient information across sites and types of providers and over time. The annual
medical databases include private-sector health data from approximately 350
payers. Historically, more than 20 billion service records are available in the
MarketScan® databases. These data represent the medical experience of insured
employees and their dependents for active employees, early retirees, Consolidated
Omnibus Budget Reconciliation Act (COBRA) continues, and Medicare-eligible
retirees with employer-provided Medicare Supplemental plans.
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Commercial Claims and Encounters Database
The MarketScan® Commercial Claims and Encounters Database contains data
from active employees, early retirees, COBRA continuees, and dependents
insured by employer-sponsored plans (i.e., persons not eligible for Medicare).
Medicare Supplemental
The MarketScan® Medicare Supplemental and Coordination of Benefits (COB)
Database is created for Medicare-eligible retirees with employer-sponsored
Medicare Supplemental plans. This database contains predominantly fee-forservice plan data. (MarketScan 2015, p. 3).
The MarketScan® databases used are deidentified. The Medical University of
South Carolina (MUSC) Institutional Review Board has previously classified studies that
use these data as non-human research.
Definition of Variables
The outcome variable for H3 in this study will be costs for TSA patients, defined
as the 90-day period following TSA. These costs will include itemized reimbursements
and grouped DRG reimbursements for TSA. Itemized reimbursements will include the
following: surgery, anesthesia, PACU observation (admission/discharge), radiology
(intraoperative/postoperative), laboratories (intraoperative/postoperative), physical
therapy/occupational therapy (inpatient/outpatient), home healthcare, and prescription
medications (Cancienne et al., 2017). The outcomes for H1 and H2 will be binary
variables indicating any complication or readmission within 90 days following TSA and
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for those patients with > 2 comorbid conditions. The hospital readmission period starts on
the day the patient is discharged from said facility. This period ends on day 91 following
discharge (Cancienne et al., 2017; CMS, 2018).
Potential covariates for costs associated with inpatient and outpatient TSA are
comorbidities such as, hyperlipidemia, hypertension, diabetes, congestive heart failure,
peripheral vascular disease, coronary artery disease, chronic lung disease, chronic kidney
disease, chronic liver disease, depression, inflammatory arthritis, hypercoaguable
disorder, hypothyroidism, hemodialysis, and chronic anemia (Cancienne et al., 2017;
Famg, Zingmond, Krenek, Soohoo, 2011; Waterman et al., 2015). Other independent
variables such as sex, race, age, postoperative complications, and readmissions.
These complications have been reported in other matched database studies
evaluating TSA. Post-operative medical complications after a TSA will include venous
thromboembolism, pulmonary embolism, lower extremity deep venous thrombosis,
urinary tract infection, pneumonia, myocardial infarction, acute renal failure,
cerebrovascular accident, and blood transfusion. Shoulder-specific complications after
TSA included infection with 90 days of procedure, dislocation within 90 days, loosening
within 90 days, stiffness within 90 days, periprosthetic fracture within 90 days, and
revision total shoulder arthroplasty within 90 days, and open and closed reduction within
90 days. Hospital readmissions within 90 days postoperatively will be measured (AHRQ,
2018; Cancienne et al., 2017; Famg, Zingmond, Krenek, Soohoo, 2011; Waterman et al.,
2015). Diagnosis codes for the complications are listed in Table 1.
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The comorbid conditions matched and controlled for in this study may include
diabetes, tobacco use, obesity, sex, age group (grouped in decades), coronary artery
disease, chronic kidney disease, and chronic anemia diagnosis inside of a year of the
TSA, Charlson Comorbidity Score, and Seamon Frailty Score (Cancienne et al., 2017;
Famg, Zingmond, Krenek, Soohoo, 2011; Waterman et al., 2015).
Table 1 ICD-9 Codes for comorbid conditions
Description
Code
Demographics characteristics
Obesity
278.00, V85.30-V85.39
Morbid Obesity
278.01, V85.40-V85.45
Tobacco Use
305.1
Alcohol Abuse
303.x, 305.00-305.03
Comorbidities
Chronic Anemia
280, 281.2, 285.2, 285.8-285.9
Chronic Kidney Disease
585.1-585.6, 585.9
Chronic Liver Disease
571.0-571.6, 571.8-571.9
Chronic Lung Disease
491.0-491.2, 491.9, 492.0, 492.8, 496
Congestive Heart Failure
428
Coronary Artery Disease
414.00-414.07, 414.2-414.4, 414.8414.9
Depression
300.4, 301.12, 309.00, 309.1, 311
Diabetes Mellitus
250 (250.00-250.39)
Hemodialysis
585.5-585.6, V45.11-V45.12, 39.95
Hypercoaguable Disorder
286.9, 289.81-289.82
Hyperlipidemia
272.0-272.9
Hypertension
401.x-405.x
Hypothyroidism
243, 244
Inflammatory Arthritis
696.0, 714.0, 720.0
Peripheral Vascular Disease
443.9
(Cancienne et al., 2017; Famg, Zingmond, Krenek, Soohoo, 2011; Waterman et al.,
2015)
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Table 2 ICD-10 codes for comorbid conditions
Description
ICD-10 Codes
Demographic Characteristics
Obesity
E66.9, Z68.30-Z68.39
Morbid Obesity
E66.01, Z68.40-Z68.45
Tobacco Use
F17.200
Alcohol Abuse
F10.10
Comorbidities
Chronic Anemia
D51.1, D51.3, D51.8, D52.0, D52.1, D52.8,
D52.9, D64.4, D64.89, D64.9
Chronic Kidney Disease
N18.1-N18.6, N18.9
Chronic Liver Disease
K70.0-K70.6, K76.0, K76.89, K74.1, K76.9
Chronic Lung Disease
J41.0-1, J41.8, J42, J43.9, J44.9
Congestive Heart Failure
I50.9
Coronary Artery Disease
I25.10, I25.810, I25.811, I25.812, I25.82, I25.83,
I25.84, I25.5, I25.89, I25.9
Depression
F34.1, F43.21, F32.9
Diabetes Mellitus
E11.8, E11.9, E10.9, E11.65, E10.65, E11.69,
E10.10, E11.00, E11.01, E10.69, E11.641,
E10.11, E10.641, E10.11, E11.29, E10.29,
E11.21, E11.311, E11.319, E11.36, E11.39,
E10.311, E10.319, E10.36, E10.39, E11.40,
E10.40, E11.51, E10.51, E11.618, E11.620,
E11.621-622, E11.628 ,E11.630, E11.638,
E11.649, E11.65, E11.69, E10.618, E10.620-622,
E10.628, E10.630, E10.638, E10.649
Hemodialysis
N18.5, N18.6, Z99.2, Z91.15
Hypercoaguable Disorder D68.8, D68.9, D68.51, D68.52, D68.59, D68.61,
D68.62, D68.69
Hyperlipidemia
E78.0-E78.9
Hypertension
I97.3, I10, I15.0, I15.8, I15.9, I12
Hypothyroidism
E00.9, E03.9
Inflammatory Arthritis
L40.54, L40.59, M06.9, M45.9
Peripheral Vascular
I73.9
Disease
(Cancienne et al.; AHRQ)
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Table 3 ICD-10 and CPT codes for postoperative complications
Description
Codes
Medical
Acute Myocardial Infarction
I21.09, I21.19, I21.11, I21.29, I21.4,
I21.3
Acute Renal Failure
N00.3, N17.0-N17.4, N19
Blood Transfusions
CPT: 36430; ICD-10: T80.89XA
Cerebrovascular Accident
60.9, I62.1, I62.00, I62.9, I65.1, I63.22,
I65.29, I63.139, I63.239, I65.09, I63.019,
I63.119, I63.219, I65.8, I63.59, I65.8,
I63.20, I65.9, I66.09, I66.19, I66.29,
I63.30, I66.9, I63.40, I63.50
Deep Venous Thrombosis, Lower- I82.409, I82.419, I82.429, I82.439,
Extremity
I82.4Y9, I82.449, I82.499, I82.4Z9
Deep Venous Thrombosis, UpperI82.629, I82.609, I82.A19, I82.B19
Extremity
Pneumonia
J12.0-J12.1, J13, J18.1, J15.0-J15.9
Pulmonary Embolism
I26.90, I26.99
Urinary Tract Infection
A54.00, A54.29, A54.21, N39.0,
T83.51XA
Shoulder-Specific
CPT: 36430; ICD-10: T80.89XA
Periprosthetic Fracture
T84.049A
Periprosthetic Loosening
T84.029A
Postoperative or Periprosthetic
CPT: 10180, 20005, 23030, 23031,
Infection
23040; ICD-10: M00.019, M00.119,
M00.219, M00.819, M01.X19, M01.X19,
T84.50XA, T84.60XA, T84.7XXA,
T85.79XA, T81.4XXA, K68.11,
T81.4XXA
Revision Shoulder Arthroplasty
CPT: 23473, 23474; ICD-10: Z96.611612
Shoulder or Periprosthetic
M24.419, S43.006A, S43.016A,
Dislocation
S43.026A, S43.036A
Open Reduction
Closed Reduction
Shoulder Stiffness
CPT: 23700; ICD-10: M24.619,
M25.619, M75.00
(Cancienne et al.; AHRQ)
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Dataset Description
Two datasets will be used in this study. The first dataset is the 2016 Medicare 5%
limited data set.
The second dataset is the Truven Health MarketScan ® privately-insured database.
These datasets were abstracted for clinical, demographic, and cost data for TSAs
performed in 2016. All of this data was covered by ICD-10 and current CPT codes. This
data are available through the Agency for Healthcare Research and Quality (AHRQ) and
the Healthcare Cost and Utilization Project (H-CUP) to The Medical University of South
Carolina and is facilitated by Dr. Kit Simpson. The training required by H-CUP was
completed by the student and signed the user data agreement.
The variables analyzed within these datasets were age, sex, race (available in
HCUP, not in MarketScan®), medical comorbidities (see table I), complications, risk
factors for readmission and 90-day costs following the procedure.
Data Analysis
H3 will utilize using a gamma-distributed log-link model and linear regression
models to evaluate costs. H1 and H2 will be using logistic regression models and odds
ratios to compare binary variables and outcomes such as demographics (age, sex, payor),
risk factors and reasons for readmissions, and complications for outpatient and inpatient
TSA patients (Cancienne et al., 2017). Odds ratios (OR) will be calculated for the
continuous variables of interest with 95% confidence intervals (CIs) and significance will
be set a priori at p < 0.05. As overall risk of any complication was a rare event, a
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modified Poisson regression model with robust error variance estimation (‘sandwich error
variance’; Zhou, 2004) was used to yield risk ratios.
Total cost and all medical bills for 90 days post-surgery will be compared and will
include the following: institutional fees, and surgical fees will be evaluated and compared
for outpatient and inpatient TSA including: surgery (surgical CPT code), concomitant
procedures, anesthesia, intraoperative and postoperative imaging, PACU observation,
discharge, intraoperative and postoperative laboratories and pathology, inpatient and
outpatient physical therapy and occupational therapy, home health (excluding physical
and occupational therapy), follow-up visits, pharmaceuticals (narcotics, antiinflammatories, muscle relaxants, antibiotics, anticoagulants, antiemetics), and grouped
reimbursements DRG (Cancienne et al., 2017). The cost of care associated with these
morbidities should be the same. Student T-test will be used to compare mean cost data
per patient comparing outpatient and inpatient TSA patients. Chi square testing will be
used for categorical variables. All analyses will be performed using SAS 9.4 (Cary, NC)
and SPSS v. 24 for Apple (Armonk, NY).
Limitations
Administrative data are generated from medical claims produced by bills and
reimbursement for those bills. Largely, this data is considered reliable, especially data
that is derived from reimbursements or payments. However, there are also limitations
associated with this type of data. This study utilizes claims data from Medicare and
commercial insurance payers. According to ResDAC, Research Data Assistance Center,
administrative data claims are limited by the following:
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1. Record of Care Received - The data is dependent upon only those diagnoses that
are reported. As result, there may be certain pathologies that are underreported by
the patient or the provider, thus increasing bias.
2. Diagnosis Information – The information provided in the administrative record
may not be comprehensive or detailed enough to provide accurate analysis of the
data.
3. Inconsistencies in the Use of Coding Systems by Care Setting – The difficulties
associated with pairing CPT codes, ICD-9, and ICD-10 create challenges with the
accuracy of using this data.
4. Exclusions in Utilization Data – For example, until recently prescription drug data
was not included, unsubmitted claims for rendered services, services not covered
by Medicare, until recently services under Medicare part B were not included,
until recently those in managed care were not included, aspects of Medicare part
D are excluded, payments to providers is not provided by encounter data.
5. Variable Quality – Generally, the information is considered good quality if it
influences payments.
Generally, when using administrative data it is recommended to use data dictionaries as a
source of consistency, reliability, and quality. This will help to ensure your data is less
biased and more consistent (Vernig & Parsons, 2018).

CHAPTER IV
ARTICLE MANUSCRIPT
Introduction

The leading indication for OA is total joint arthroplasty (TJA) (Sloan &
Hanrahan, 2014; Kurtz, et. al., 2007). As the prevalence of OA continues to increase, so
will the need for TJA surgery. Shoulder osteoarthritis, in particular, and the resulting
treatment of total shoulder arthroplasty (TSA), has grown at a rate of 9.4% annually in
the United States and is projected to exceed that of total knee arthroplasty (TKA) and
total hip arthroplasty (THA) (Day et al., 2010).

Historically, TJA and TSA have proven to be safe procedures. Surgeons have
translated their good outcomes from inpatient TJA into the outpatient setting with good
results. These outcomes have motivated orthopedic surgeons to increase the use of TSA
in the outpatient setting as well (Berger et al., 2009; Courtney et al., 2016). In the
outpatient setting, it is vital to avoid costly complications and readmissions.
Postoperative complications and unplanned hospital admissions following outpatient TJA
and TSA can increase costs following the procedure. In turn, this will decrease the value
associated with outpatient TSA

Decreasing costly complications will decrease the costs associated with inpatient
TSA such as overnight charges, hospital charges, nursing, labs, and medications
(Crawford, Li, Sprague, & Bhandari, 2015) In fact, Previous studies have shown the three
major drivers for cost are operating room costs, medical device costs, and length of stay
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in the hospital (Bosco, et al., 2014; Healy et al., 1998; Healy et al., 1998; Raphael et al.,
2014; Steinhaus et al., 2018). While intraoperative costs, such as operating room time and
surgical implants may be common to both inpatient and outpatient TSA surgery,
elimination of the inpatient stay altogether can eliminate the third major cost driver—
assuming the correct patients are chosen for outpatient TSA.
Using protocols and care pathways to educate patients, identify high-risk patients
for complications, and redirecting those patients toward inpatient TSA is paramount to
successful implementation of outpatient TSA (Kim and Iorio, 2017; Brolin and
Throckmorton, 2018; Lombardi et al., 2016). Protocols and pathways will encourage
value by decreasing costs and improving outcomes by encouraging only high-risk
patients to have their surgeries performed in the inpatient setting; low risk patients would
be encouraged to have their surgery performed in an outpatient setting, decreasing costs.
Healthcare spending in the United States is increasing dramatically and healthcare
leaders are looking for ways to decrease costs and encourage value. Current spending in
the US is nearly $3.5 trillion annually, or nearly 18% of the Gross Domestic Product
(Berland, Rocco & Walden, 2015; Bryan, 2016). Therefore, value is crucial to the future
to of our healthcare system. Value is defined as “health outcome per dollar of cost
expended” (Porter & Olmsted-Teidsberg, 2006, p.4). Therefore, healthcare experts are
focused on finding strategies to improve outcomes and decrease costs. According to
Porter & Olmstead-Teidsberg, they believe “the structure of healthcare delivery” is
essential to the success of our healthcare system (Porter & Olmstead-Teidsberg, 2006,
p.3).
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TJA is the largest procedural consumer of Medicare’s budget at 6.3% annually
(Dobson et al., 2012). Outpatient TSA is one way to decrease these costs and increase
value for consumers to ensure the solvency of the US healthcare system. To date, there
has been little work focused on comparing outpatient TSA versus inpatient TSA and the
potential cost savings. This study will ameliorate this problem by selecting only patients
in both inpatient and outpatient settings who could genuinely have their surgery done in
the outpatient setting; as all of the patients in this study are not high risk.
TJA is the largest procedural consumer of Medicare’s budget at 6.3% annually
(Dobson et al., 2012). Outpatient TSA is one way to decrease these costs and increase
value for consumers to ensure the solvency of the US healthcare system. To date, there
has been little work focused on comparing outpatient TSA versus inpatient TSA and the
potential cost savings. This study will ameliorate this problem by selecting only patients
in both inpatient and outpatient settings who could genuinely have their surgery done in
the outpatient setting; as all of the patients in this study are not high risk.
As value is becoming increasingly important, healthcare leaders must continue to
seek out and find ways to balance cost savings with uncompromising patient safety.
Outpatient TSA should not be an option for every patient; likewise, inpatient TSA should
not be a consideration for every patient. Healthcare providers and patients need to be
responsible enough to avoid costly errors by treating those patients with significant
medical risks as inpatient. However, providers and patients should also encourage value
by facilitating outpatient TSA for those patients who qualify. As our population ages,
increasing numbers of people will develop osteoarthritis, resulting in increased need for
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TSA, which will drive up healthcare costs. Therefore, healthcare leaders should strive to
ensure this procedure is delivered in the most cost-effective manner.
The primary goal of this study was to determine the marginal cost differences and
complication rates of total shoulder arthroplasty performed in an outpatient setting
compared with that same procedure performed in an inpatient setting in a well-matched
group of low to medium preoperative risk patients; these are patients whose surgery
could have been performed in either an inpatient or outpatient setting. The authors
hypothesized that the rate of complications would be lower in the outpatient setting. The
authors also hypothesized costs would be lower in the outpatient setting.
Methods
Data
This retrospective study was conducted using the two databases: Truven Health
MarketScan® Commercial Claims and Encounters database (patients aged 55-64), as well
as the Truven Health MarketScan Medicare supplemental insurance database (patients
aged 65-74) for the 2016 claims year were used. These data included health insurance
claims across the continuum of care (e.g., inpatient, outpatient, outpatient pharmacy,
carve-out behavioral health care) as well as enrollment data from >100 large employers
and health plans across the United States who provide private health care coverage for
more than 50 million employees, their spouses, and dependents. This administrative
claims database also includes a variety of fee-for-service, preferred provider
organizations, and capitated health plans.
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The enrollment data provided beneficiaries’ demographic data including age,
employment status, geographical region, and sex. These data also provided the
beneficiaries’ insurance plan data including plan type and enrollment status. Medical
service claims provide detailed inpatient and outpatient encounter information, including
date and setting of service, provider type, plan and patient-paid amounts, International
Classification of Diseases, 10th revision, Clinical Modification & Procedure Coding
System (ICD-10-CM/PCS) diagnosis and procedure codes, Current Procedural
Terminology, 4th edition (CPT-4) codes, and Healthcare Common Procedure Coding
System (HCPCS) procedure codes.
The MarketScan® databases used were deidentified. The Medical University of
South Carolina (MUSC) Institutional Review Board has previously classified studies that
use these data as non-human research. The Medical University of South Carolina
(MUSC) Institutional Review Board has previously classified studies that use these data
as non-human research.
Study & Control Cohorts
Patients meeting the Centers for Medicare and Medicaid services (CMS)
definition for elective anatomic total shoulder arthroplasty during 2016 were included in
this study. This definition includes having a CPT code of 23472 or ICD-10-PCS
procedure Z96.611 or Z96.612 (left or right, respectively). Patients had to be continually
insured for 6 months pre-TSA and 3 months post-TSA. The patient’s first claim date for
TSA served as the index date, and the patient was followed for 3 months post-TSA to
ascertain total costs and post-operative complication rates. Patients who underwent
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reverse TSA and hemiarthroplasty were excluded from the study, as these patient
populations can be different than those seeking elective anatomic TSA secondary to
osteoarthritis. Patients were further excluded if they had an acute proximal humerus
fracture (S42.201A) or osteonecrosis of the proximal humerus (M87.811).
Propensity score matching
Propensity score matching was used as the study design method to model the
probability that a patient could have had his or her surgery in the outpatient setting, to
ensure only those patients who could have reasonably had their surgery in the inpatient or
outpatient setting entered the study. We used a Greedy (nearest neighbor) 1:1 matching
algorithm without replacement with the caliper distance of less than 0.1 standard
deviations of the logit. The comorbid conditions matched and controlled for in this study
included diabetes, tobacco use, alcohol use disorder, obesity, sex, age group (grouped in
decades), coronary artery disease, chronic kidney disease, and chronic anemia diagnosis
inside of a year of the TSA, Charlson Comorbidity Score, and Seamon Frailty Score (See
Tables 1-3) (Cancienne et al., 2017; Famg, Zingmond, Krenek, Soohoo, 2011; {Seamon,
Publication forthcoming}; Waterman et al., 2015).
Outcomes
Our primary outcome was any post-operative medical or surgical complication in
the 90 days following the procedure. Medical complications included venous
thromboembolism, pulmonary embolism, lower extremity deep venous thrombosis,
urinary tract infection, pneumonia, myocardial infarction, acute renal failure,
cerebrovascular accident, and blood transfusion. Shoulder-specific complications
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included infection, dislocation, loosening of implant, stiffness, periprosthetic fracture,
and revision TSA, and open or closed reduction.. Diagnosis codes for the complications
are listed in Table I.
Our secondary outcome was total amount paid in the 90 days following the
procedure. These included all inpatient and outpatient insurance payments, including for
prescription medications and rehabilitation. Since the groups being compared were
propensity score matched, the marginal cost of care between inpatient and outpatient
cohorts should reflect the difference associated with the surgical setting and care
following the procedure, and not of underlying comorbid burden.
Statistical Analysis
Descriptive statistics were used to compare the characteristics of the two cohorts
both pre- and post-matching. Means and standard deviations were calculated to describe
continuous data; frequencies and percentages were calculated to describe categorical
data. Chi-square statistics were used to test for differences in proportions. Two-sample
Student’s t-tests were used for normally-distributed data and Wilcoxon rank-sum/MannWhitney U statistics were used to test for differences in medians (or ranks) of nonnormally distributed continuous data.
Patient-specific variables considered for inclusion in regression models included
age (grouped as 55-64 and 65-74), sex, geographic region, and Charlson comorbidity
score. Race and ethnicity are not available in MarketScan databases. Consistent with
prior studies, we also examined comorbidities such as, hyperlipidemia, hypertension,
diabetes, congestive heart failure, peripheral vascular disease, coronary artery disease,
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chronic lung disease, chronic kidney disease, chronic liver disease, depression,
inflammatory arthritis, hypercoaguable disorder, hypothyroidism, hemodialysis, and
chronic anemia (See Tables 1-3) (Cancienne et al., 2017; Famg, Zingmond, Krenek,
Soohoo, 2011; Waterman et al., 2015).
For the primary outcome, multiple logistic regression was used to compare the
complication rates between the inpatient and outpatient settings. The main independent
variable in these regressions was a binary indicator of whether the surgery occurred in the
inpatient setting. Covariate adjustment was used to control for differences in rates of
failure which may be attributable to other factors. Covariates were assessed for
collinearity using Pearson correlation coefficients; no collinearity was found in these data
(all p > 0.25). This model was then re-run using a modified Poisson regression model to
provide more robust adjusted Odds Ratios (OR) and corresponding 95% confidence
interval estimates. As overall risk of any complication was a rare event, a modified
Poisson regression model with robust error variance estimation (‘sandwich error
variance’; Zhou, 2004) was used to yield risk ratios.
For the secondary outcome, a gamma-distributed log-transformed generalized
linear model was ran. Covariates were selected for inclusion and examination for
confounding on the basis of clinical relevance. Traditional model fitting procedures
(Akaike Information Criterion and log-rank tests) were used to assess the value of each
independent variable in the model. The final parsimonious models included independent
variables, as listed in tables 5-7.
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All analyses were performed using SAS version 9.4 (Cary, NC) and SPSS v. 24
for Apple (Armonk, NY). Statistical significance was set a priori at α<0.05. The
institutional review board of the Medical University of South Carolina reviewed this
study protocol and approved it as nonhuman subjects research, given the deidentified
nature of the data.
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Results

Table 4 Demographics and characteristics of patients prior to propensity score
matching
Outpatient
Inpatient
Characteristic
n=374
n=1,204
p-value
Male
224 (59.9)
659 (54.7)
.079
Age Group
.055
55-64
266 (71.1)
792 (65.8)
65-74
108 (28.9)
412 (34.2)
Diabetes, complicated
22 (5.9)
69 (5.7)
.913
Diabetes, uncomplicated
43 (11.5)
164 (13.6)
.288
Hypertension, complicated
7 (1.9)
28 (2.3)
.603
Hypertension, uncomplicated
184 (49.2)
585 (48.6)
.837
Obesity
45 (12)
94 (7.8)
.012
Charlson Score
0.14 ±0.47
0.30 ±0.62
.000
Frailty Category
.040
Robust
232 (62.0)
663 (55.1)
Pre-frail or frail
142 (38.0)
541 (44.9)
All values are expressed as: mean ±S.D., or n (%)
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Table 5 Demographics and characteristics of patients following propensity score
matching
Outpatient
Inpatient
Characteristic
n=369
n=369
p-value
Male
222 (60.2)
205 (55.6)
.205
Age Group
.339
55-64
261 (70.7)
249 (67.5)
65-74
108 (29.3)
120 (32.5)
Diabetes, complicated
21 (5.7)
19 (5.1)
.745
Diabetes, uncomplicated
42 (11.4)
38 (10.3)
.636
Hypertension, complicated
7 (1.9)
6 (1.6)
.780
Hypertension, uncomplicated
182 (49.3)
179 (48.5)
.825
Obesity
51 (13.8)
48 (13.0)
.746
Urinary Tract Infection
12 (3.3)
4 (1.1)
.043
Readmission
5 (1.4)
0 (0.0)
.025
Any complication
35 (9.5)
16 (4.3)
.006
Charlson Score
0.14 ±0.47
0.11 ±0.38
.388
Total Payments
$13,514
$32,992
.000
[$5,238 to $29,114] [$22,427 to $44,031]
All values are expressed as: n (%), mean ±SD, or median [IQR]
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Table 6 Parameter Estimates for Total Costs in the 90-day period following surgery
Parameter
β
95% C.I.
p-value
Intercept
9.7503
(9.6282 – 9.8723)
<.0001
Inpatient
0.6268
(0.5155 – 0.7380
<.0001
ETOH abuse
-1.0329
(-2.5291 – 0.4634)
0.1761
Tobacco use disorder
0.2361
(-0.1429 – 0.6151)
0.2220
Obese
0.0833
(-0.0566 – 0.2231)
.2432
Frailty Category
-0.0453
(-0.1599 – 0.0694)
0.4388
Male
0.1132
(0.0008 – 0.2255)
0.0484
Charlson score 1
0.4767
(0.2626 – 0.6908)
<.0001
Charlson score 2+
0.4955
(0.1460 – 0.8450)
0.0055

Table 7 Parameter estimates and odds ratio estimates for any complication
Parameter estimates
Odds ratios
Parameter
β
95% C.I.
p-value
OR
95% C.I.
Intercept
-2.337
-2.79 to -1.89
<.0001
Inpatient
-0.771
-1.34 to -0.20
0.008
0.436 0.261 to 0.818
Diabetes
0.311
-0.39 to 1.01
0.382
1.346 0.680 to 2.742
Obese
-0.238
-0.963 to 0.488
0.521
0.789 0.382 to 1.630
Male
-0.164
-0.685 to 0.358
0.538
0.836 0.504 to 1.430
Charlson score 1
0.176
-0.788 to 1.140
0.721
1.166 0.455 to 3.125
Charlson score 2+
1.108
0.167 to 2.048
0.021
3.513 1.182 to 7.755
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We identified 1,578 patients who underwent TSA patients: 374 in the outpatient
setting and 1,204 in the inpatient setting. After propensity score matching, 369
participants in each group were used to compare the effect of surgery setting on
complication rate and costs.
Table 1 presents the differences between patients undergoing TSA in the inpatient
versus the outpatient setting. Among these patients, the mean Charlson score was nearly
double in the inpatient population (0.14 vs. 0.30, p<0.001). However, the outpatient
population had higher rates of obesity than the inpatient group (12% vs 7.8%, p=.012).
Propensity score matching yielded an overall 96.68% reduction in bias, with all
covariates satisfying the minimum reduction in bias to an absolute standardized
difference in means of less than 0.1 after matching. These propensity score matched
patients then entered the study for analysis.
Table 2 presents the differences between patients undergoing TSA and inpatient
versus outpatient setting, among those propensity score matched and in the study. Among
these, urinary tract infections were more frequent in the outpatient TSA group (3.3% vs
1.1%, p=.043). Furthermore, there were more complications of any type for outpatient
(9.5% vs 4.3%, p=.006) compared to inpatient and 3 times as many medical
complications (5.7% vs. 1.6%, p=.003). Lastly, payments were substantially less for
those patients undergoing outpatient TSA (Mean, $13,514 vs $32,992, p<0.001).
In the analysis to compare total amounts paid in the 90 days following surgery
between inpatient and outpatient total shoulder arthroscopies, it was found that inpatient
surgeries cost more than outpatient surgeries (p<.0001) while controlling for the
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confounding factors of alcohol abuse, tobacco use disorder, obesity, frailty category, sex,
and Charlson category (categorized as 0, 1, 2+). Total costs for inpatients were 87%
higher at $36,033 vs. $19,253 for outpatient TSA (p=0.0001). Other significant
contributors to cost differences included patients who were male (p=0.0484), and those
with increased medical morbidities, as denoted by Charlson scores of 1 or 2+ (p<0.0001
and p=0.0055, respectively). The analysis of maximum likelihood parameter estimates
are found in table 3.
In the analysis to compare complication rates following surgery between inpatient
and outpatient total shoulder arthroscopies, it was found that patients who had their TSA
performed in an inpatient setting were at a 53.8% lower risk of a complication than those
who had their TSA performed in an outpatient setting (Odds Ratio [OR] = 0.462, 95%
CI: 0.261 to 0.818; p=0.008). In our modeling we also found that those with the Charlson
score of 2 or greater had 3 times the odds of a complication over those whose Charlson
score was zero (OR: 3.03, 95% CI: 1.18 to 7.75; p=0.021).
Discussion
Current spending in the US is nearly $3.5 trillion annually, or nearly 18% of the
Gross Domestic Product (Berland, Rocco & Walden, 2015; Bryan, 2016). Therefore,
value is crucial to the future to of our healthcare system. However, this desire to increase
value must be balanced with safety.
Outpatient TSA is one way to decrease these costs and increase value for
consumers to ensure the solvency of the US healthcare system. Using protocols and care
pathways to educate patients, identify high-risk patients for complications, and
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redirecting those patients toward inpatient TSA is paramount to successful
implementation of outpatient TSA (Kim and Iorio, 2017; Brolin and Throckmorton,
2018; Lombardi et al., 2016). These protocols and pathways will encourage value by
decreasing costs and improving outcomes by encouraging only high-risk patients to have
their surgeries performed in the inpatient setting; low risk patients would be encouraged
to have their surgery performed in an outpatient setting, decreasing costs. Moreover, it
will create a perioperative environment promoting success by following the
aforementioned principles for outpatient TSA patients, thus decreasing complications and
unplanned hospital admissions. These complications and unplanned hospital admissions
following inpatient and outpatient TSA can be costly.
It is extremely important to establish value for ambulatory, outpatient, and
inpatient TSA; however, we must also corroborate the safety of outpatient TSA.
Decreasing costly readmissions and visits to the ED is vital to the efficacy of outpatient
surgery and to our healthcare system. So that outpatient TSA can be successful, we must
establish protocols and pathways highlighting those patients best suited for the outpatient
setting. These patients will have less comorbidities and will be less likely to be
readmitted or visit the ED following discharge.
This study investigated whether outpatient TSA offers a cost advantage over
inpatient TSA. Moreover, we examined which option had a higher risk of readmissions
and complications.
Hypothesis 1 (H1), is do patients who undergo total shoulder arthroplasty in an
outpatient setting will have lower complication rates than those in an inpatient setting.
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No, our study shows an increased rate of complications. There were more complications
of any type for outpatient (9.5% vs 4.3%, p=.006) compared to inpatient and 3 times as
many medical complications (5.7% vs. 1.6%, p=.003). UTI’s were more frequent in the
outpatient TSA (3.3% vs 1.1%, p=.043). This could represent a lack of screening or less
healthy patients being directed toward the outpatient setting. Likewise, there were more
complications of any type for outpatient (9.5% vs 4.3%, p=.006) compared to inpatient
and 3 times as many medical complications (5.7% vs. 1.6%, p=.003). These findings are
contrary to Cancienne et al., which showed no differences in outpatient TSA and
inpatient TSA while comparing all postoperative complications (p.<.05). The control
group had a lower rate of urinary tract infection (6.8 <8.7%) (p<0.003) and blood
transfusions (3.5%<4.7%) (p<0.028). Overall the control group had a higher rate of
medical and systemic complications postoperatively at 90 days (15.9%,17.7%) (p<0.012).
Each of these findings represent increased urgency to maintain protocols and pathways.
Moreover, as healthcare leaders and clinicians we must be careful not substitute value for
quality of care.
Recognizing those patients with risk factors and increased medical morbidity is
paramount to maintaining the value associated with outpatient TSA. If patients have
outpatient surgery and return to the hospital for readmission or ED, then costs will be
higher (Chalmers et al., 2014; Courtney et al., 2017; Dunn et al., 2015, Waterman et al.,
2015). Other authors have shown a correlation between preoperative medical morbidities
and post-operative complications (Cancienne et al., 2017; Chalmers et al., 2014).
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Hypothesis 2 (H2), is do patients who undergo total shoulder arthroplasty in an
outpatient setting will have lower readmission rates than those in an inpatient setting?
No, patients in the outpatient setting have a higher readmission rate than those in the
inpatient. Those patients requiring readmission were greater in the outpatient TSA group
5(1.4) vs. 0(0.0); (p=.025). One way to ameliorate these risks factors, visits to the ED,
and readmissions is by using protocols and pathways. Identifying high-risk patients by
using standardized protocols requires a multidisciplinary approach. Using the CCI is one
way to monitor medical risk factors and redirect high-risk patients toward the inpatient
setting (Brolin and Throckmorton 2018; Chalmers et al., 2015; Kim and Iorio 2017;
Lombardi et al. 2016). Our study showed patients with increased medical morbidity and
Charlson Category Score +1 were nearly 48% (95% CI: 0.2626 – 0.6908; p<0.0001)
more expensive and those patients with Charlson Category Score of +2 were 50% more
expensive (95% CI: 0.1460 – 0.8450; p=0.0055).
Hypothesis 3 (H3), is do patients who undergo total shoulder arthroplasty in an
outpatient setting will have lower costs than those in an inpatient setting. Yes, payments
were substantially less for those patients undergoing outpatient TSA (Mean, 19902.44 vs
35931.47, p=.000). Exponentiated Costs are equal to the Total Paid, while adjusting for
other covariates. Total exponentiated costs for inpatient were 87% higher at $36,033
(95% CI: 33323 – 38963; p<0.0001), while outpatient TSA was $19,253 (95% CI: 17805
– 20819; p=0.0001). These findings are consistent with other studies showing a cost
savings with outpatient TSA (Aynardi et al. 2014; Cancienne et al. 2017; Crawford, Li,
Sprague & Bhandari, 2015; Lovald et al. 2014; Steinhaus et al. 2018). Moreover,
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Cancienne et al. showed a median cost savings of just $3614, while our findings were
showed a much higher cost savings of $16,780. This difference could be attributed to
ICD-10 and the ACA as our study included patients from 2016, while Cancienne et al.
evaluated patients from 2010-2014 prior to ICD-10.
This study had several limitations. Many of them are broad and related to using
administrative data. First, the record of care could be unreliable due to lack of
documentation, thus skewing the information. Specifically, patients in this cohort could
be seen within the 90 day postoperative period for minor complications with
documentation, but without coding. (Cancienne et al., 2017; Resdac, 2018). Second,
although ICD-10 is more detailed and this could also be considered a strength of this
study, diagnostic information may not be comprehensive. Third, there could
inconsistencies in coding or procedures with different clinical settings. Fourth, there are
variables that cannot be controlled for such as surgical technique, hospital volume,
operative time, and anesthesia. Further, while patients were matched, we could not
control for those patients who were discharged and pursued their own care at outpatient
or inpatient rehabilitation facilities. Fifth, patients were propensity score matched and
multivariate regression was employed, but there was likely some selection bias in
choosing healthier patients for outpatient TSA. Sixth, reimbursements could vary for
TSA secondary to contracts, facilities, and geographic locations. Seventh, our
complications encompassed 90 days postoperatively. Some of these complications may
be more likely to occur after 90 days such as dislocation, periprosthetic fracture,
infection, and loosening of the prosthesis. This could affect the affect the complication
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rate. Eighth, we examined only one year of data, 2016. Finally, our study identified
complications, but did not elaborate on specific complications (Cancienne et al., 2017;
ResDac, 2018).
In conclusion, our results show that outpatient TSA provides a significant cost
reduction. However, there was an increase in complications. This is contrary to previous
work published by Cancienne et al. Therefore, future work should focus on evaluating
outpatient TSA, its value, and its safety within ICD-10 and the ACA. Additionally,
healthcare leaders should focus on identifying and directing high-risk patients toward
inpatient settings, while focusing on value.
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